{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:46:14Z","timestamp":1779907574247,"version":"3.53.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA045596"],"award-info":[{"award-number":["R01 DA045596"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA041903"],"award-info":[{"award-number":["R21 DA041903"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA039942"],"award-info":[{"award-number":["R01 DA039942"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R21 DA045597"],"award-info":[{"award-number":["R21 DA045597"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011072","name":"Center for AIDS Research, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["T32 DA007244"],"award-info":[{"award-number":["T32 DA007244"]}],"id":[{"id":"10.13039\/100011072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01 DA033760"],"award-info":[{"award-number":["R01 DA033760"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17F17388"],"award-info":[{"award-number":["17F17388"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01 AI128864"],"award-info":[{"award-number":["R01 AI128864"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"crossref","award":["R01 AI091526"],"award-info":[{"award-number":["R01 AI091526"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11481-019-09867-w","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T06:02:48Z","timestamp":1564639368000},"page":"661-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Inhibitory Control Deficits Associated with Upregulation of CB1R in the HIV-1 Tat Transgenic Mouse Model of Hand"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-5224","authenticated-orcid":false,"given":"Ian R.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis F.","family":"League","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J.","family":"Niphakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogna M.","family":"Ignatowska-Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Fitting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"9867_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbi.2014.02.016","volume":"40","author":"S Acharjee","year":"2014","unstructured":"Acharjee S, Branton WG, Vivithanaporn P, Maingat F, Paul AM, Dickie P, Baker GB, Power C (2014) HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain Behav Immun 40:74\u201384. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2014.02.016","journal-title":"Brain Behav Immun"},{"key":"9867_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/cr0782067","volume":"108","author":"K Ahn","year":"2008","unstructured":"Ahn K, McKinney MK, Cravatt BF (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108:1687\u20131707. \nhttps:\/\/doi.org\/10.1021\/cr0782067","journal-title":"Chem Rev"},{"key":"9867_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.chembiol.2009.02.013","volume":"16","author":"K Ahn","year":"2009","unstructured":"Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK, Weerapana E, Sadagopan N, Liimatta M, Smith SE, Lazerwith S, Stiff C, Kamtekar S, Bhattacharya K, Zhang Y, Swaney S, Van Becelaere K, Stevens RC, Cravatt BF (2009) Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16:411\u2013420. \nhttps:\/\/doi.org\/10.1016\/j.chembiol.2009.02.013","journal-title":"Chem Biol"},{"key":"9867_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1460-9568.2009.07047.x","volume":"31","author":"VM Andre","year":"2010","unstructured":"Andre VM, Cepeda C, Cummings DM, Jocoy EL, Fisher YE, William Yang X, Levine MS (2010) Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. Eur J Neurosci 31:14\u201328. \nhttps:\/\/doi.org\/10.1111\/j.1460-9568.2009.07047.x","journal-title":"Eur J Neurosci"},{"key":"9867_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/path.2276","volume":"214","author":"V Appay","year":"2008","unstructured":"Appay V, Sauce D (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214:231\u2013241. \nhttps:\/\/doi.org\/10.1002\/path.2276","journal-title":"J Pathol"},{"key":"9867_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nprot.2008.41","volume":"3","author":"A Bari","year":"2008","unstructured":"Bari A, Dalley JW, Robbins TW (2008) The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc 3:759\u2013767. \nhttps:\/\/doi.org\/10.1038\/nprot.2008.41","journal-title":"Nat Protoc"},{"key":"9867_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-131910","volume":"40","author":"G Bedse","year":"2014","unstructured":"Bedse G, Romano A, Cianci S, Lavecchia AM, Lorenzo P, Elphick MR, Laferla FM, Vendemiale G, Grillo C, Altieri F, Cassano T, Gaetani S (2014) Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 40:701\u2013712. \nhttps:\/\/doi.org\/10.3233\/JAD-131910","journal-title":"J Alzheimers Dis"},{"key":"9867_CR8","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","volume":"23","author":"C Benito","year":"2003","unstructured":"Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23:11136\u201311141","journal-title":"J Neurosci"},{"key":"9867_CR9","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","volume":"25","author":"C Benito","year":"2005","unstructured":"Benito C, Kim WK, Chavarria I, Hillard CJ, Mackie K, Tolon RM, Williams K, Romero J (2005) A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci 25:2530\u20132536. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.3923-04.2005","journal-title":"J Neurosci"},{"key":"9867_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","volume":"153","author":"C Benito","year":"2008","unstructured":"Benito C, Tolon RM, Pazos MR, Nunez E, Castillo AI, Romero J (2008) Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol 153:277\u2013285. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0707505","journal-title":"Br J Pharmacol"},{"key":"9867_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/pr.112.006387","volume":"65","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Cravatt BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol Rev 65:849\u2013871. \nhttps:\/\/doi.org\/10.1124\/pr.112.006387","journal-title":"Pharmacol Rev"},{"issue":"8","key":"9867_CR12","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","volume":"165","author":"Lamont Booker","year":"2012","unstructured":"Booker L, Kinsey, SG, Abdullah, RA, Blankman, JL, Long, JZ, Ezzili, C, Boger, DL, Cravatt, , BF, Lichtman, AH (2012) The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. Br J Pharmacol 165:2485\u20132496 doi:\nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2011.01445.x","journal-title":"British Journal of Pharmacology"},{"key":"9867_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1750-1326-9-58","volume":"9","author":"MD Boska","year":"2014","unstructured":"Boska MD, Dash PK, Knibbe J, Epstein AA, Akhter SP, Fields N, High R, Makarov E, Bonasera S, Gelbard HA, Poluektova LY, Gendelman HE, Gorantla S (2014) Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice. Molecular Neurodegeneration 9:58. \nhttps:\/\/doi.org\/10.1186\/1750-1326-9-58","journal-title":"Molecular Neurodegeneration"},{"key":"9867_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.neuroscience.2007.11.031","volume":"151","author":"GC Brailoiu","year":"2008","unstructured":"Brailoiu GC, Brailoiu E, Chang JK, Dun NJ (2008) Excitatory effects of human immunodeficiency virus 1 tat on cultured rat cerebral cortical neurons. Neuroscience 151:701\u2013710. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2007.11.031","journal-title":"Neuroscience"},{"key":"9867_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/s1471-4892(02)00011-5","volume":"3","author":"JM Brotchie","year":"2003","unstructured":"Brotchie JM (2003) CB1 cannabinoid receptor signalling in Parkinson's disease. Curr Opin Pharmacol 3:54\u201361. \nhttps:\/\/doi.org\/10.1016\/s1471-4892(02)00011-5","journal-title":"Curr Opin Pharmacol"},{"key":"9867_CR16","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/glia.20708","volume":"56","author":"AJ Bruce-Keller","year":"2008","unstructured":"Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ, Geurin T, Chauhan A, Reid R, Xu R, Nath A, Knapp PE, Hauser KF (2008) Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 56:1414\u20131427. \nhttps:\/\/doi.org\/10.1002\/glia.20708","journal-title":"Glia"},{"key":"9867_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbr.2011.12.019","volume":"229","author":"AN Carey","year":"2012","unstructured":"Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP (2012) Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res 229:48\u201356. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2011.12.019","journal-title":"Behav Brain Res"},{"key":"9867_CR18","doi-asserted-by":"publisher","first-page":"22385","DOI":"10.1074\/jbc.272.36.22385","volume":"272","author":"P Chen","year":"1997","unstructured":"Chen P, Mayne M, Power C, Nath A (1997) The tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 272:22385\u201322388","journal-title":"J Biol Chem"},{"key":"9867_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0306-4522(97)00174-7","volume":"82","author":"J Cheng","year":"1998","unstructured":"Cheng J, Nath A, Knudsen B, Hochman S, Geiger JD, Ma M, Magnuson DS (1998) Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein. Neuroscience 82:97\u2013106","journal-title":"Neuroscience"},{"key":"9867_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","volume":"29","author":"V Chevaleyre","year":"2006","unstructured":"Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37\u201376. \nhttps:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.112834","journal-title":"Annu Rev Neurosci"},{"key":"9867_CR21","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1073\/pnas.1400988111","volume":"111","author":"A Chiarlone","year":"2014","unstructured":"Chiarlone A, Bellocchio L, Blazquez C, Resel E, Soria-Gomez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sanchez-Prieto J, Lutz B, Fernandez-Ruiz J, Galve-Roperh I, Guzman M (2014) A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc Natl Acad Sci U S A 111:8257\u20138262. \nhttps:\/\/doi.org\/10.1073\/pnas.1400988111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9867_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00042560-199601010-00005","volume":"11","author":"A Chiesi","year":"1996","unstructured":"Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, Goebel FD, Glauser M, Antunes F, Lundgren JD (1996) Epidemiology of AIDS dementia complex in Europe AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 11:39\u201344","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"9867_CR23","doi-asserted-by":"publisher","first-page":"e111583","DOI":"10.1371\/journal.pone.0111583","volume":"9","author":"CG Connolly","year":"2014","unstructured":"Connolly CG, Bischoff-Grethe A, Jordan SJ, Woods SP, Ellis RJ, Paulus MP, Grant I (2014) Altered functional response to risky choice in HIV infection. PLoS One 9:e111583. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0111583","journal-title":"PLoS One"},{"key":"9867_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2990.2011.01177.x","volume":"37","author":"MA Cosenza-Nashat","year":"2011","unstructured":"Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh HS, Lee SC (2011) Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. Neuropathol Appl Neurobiol 37:464\u2013483. \nhttps:\/\/doi.org\/10.1111\/j.1365-2990.2011.01177.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9867_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/13550280490521078","volume":"10","author":"LA Cysique","year":"2004","unstructured":"Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10:350\u2013357. \nhttps:\/\/doi.org\/10.1080\/13550280490521078","journal-title":"J Neurovirol"},{"key":"9867_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-6606-3-34","volume":"3","author":"L Devi","year":"2010","unstructured":"Devi L, Alldred MJ, Ginsberg SD, Ohno M (2010) Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Mol Brain 3:34. \nhttps:\/\/doi.org\/10.1186\/1756-6606-3-34","journal-title":"Mol Brain"},{"key":"9867_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrd2553","volume":"7","author":"V Di Marzo","year":"2008","unstructured":"Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438\u2013455. \nhttps:\/\/doi.org\/10.1038\/nrd2553","journal-title":"Nat Rev Drug Discov"},{"key":"9867_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/glia.20148","volume":"50","author":"N El-Hage","year":"2005","unstructured":"El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF (2005) Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 tat. Glia 50:91\u2013106. \nhttps:\/\/doi.org\/10.1002\/glia.20148","journal-title":"Glia"},{"key":"9867_CR29","doi-asserted-by":"publisher","first-page":"e4093","DOI":"10.1371\/journal.pone.0004093","volume":"3","author":"N El-Hage","year":"2008","unstructured":"El-Hage N, Bruce-Keller AJ, Yakovleva T, Bazov I, Bakalkin G, Knapp PE, Hauser KF (2008) Morphine exacerbates HIV-1 tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF-\u03baB trafficking and transcription. PLoS One 3:e4093. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0004093","journal-title":"PLoS One"},{"key":"9867_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrn2040","volume":"8","author":"R Ellis","year":"2007","unstructured":"Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33\u201344. \nhttps:\/\/doi.org\/10.1038\/nrn2040","journal-title":"Nat Rev Neurosci"},{"key":"9867_CR31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/S1053-8119(03)00232-5","volume":"19","author":"T Ernst","year":"2003","unstructured":"Ernst T, Chang L, Arnold S (2003) Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 19:1686\u20131693","journal-title":"Neuroimage"},{"key":"9867_CR32","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.0611699104","volume":"104","author":"EA Eugenin","year":"2007","unstructured":"Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes proc. Natl Acad Sci U S a 104:3438\u20133443. \nhttps:\/\/doi.org\/10.1073\/pnas.0611699104","journal-title":"Natl Acad Sci U S a"},{"key":"9867_CR33","first-page":"209","volume":"9","author":"IP Everall","year":"1999","unstructured":"Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HIV Neurobehavioral Research Center Brain Pathol 9:209\u2013217","journal-title":"HIV Neurobehavioral Research Center Brain Pathol"},{"key":"9867_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuint.2011.11.004","volume":"60","author":"S Farkas","year":"2012","unstructured":"Farkas S, Nagy K, Palkovits M, Kovacs GG, Jia Z, Donohue S, Pike V, Halldin C, Mathe D, Harkany T, Gulyas B, Csiba L (2012) [(1)(2)(5)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease. Neurochem Int 60:286\u2013291. \nhttps:\/\/doi.org\/10.1016\/j.neuint.2011.11.004","journal-title":"Neurochem Int"},{"key":"9867_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/PL00005492","volume":"146","author":"PR Finn","year":"1999","unstructured":"Finn PR, Justus A, Mazas C, Steinmetz JE (1999) Working memory, executive processes and the effects of alcohol on go\/no-go learning: testing a model of behavioral regulation and impulsivity. Psychopharmacology 146:465\u2013472","journal-title":"Psychopharmacology"},{"key":"9867_CR36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2353\/ajpath.2010.090945","volume":"177","author":"S Fitting","year":"2010","unstructured":"Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177:1397\u20131410. \nhttps:\/\/doi.org\/10.2353\/ajpath.2010.090945","journal-title":"Am J Pathol"},{"key":"9867_CR37","doi-asserted-by":"publisher","first-page":"12850","DOI":"10.1523\/JNEUROSCI.5351-13.2014","volume":"34","author":"S Fitting","year":"2014","unstructured":"Fitting S, Knapp PE, Zou S, Marks WD, Bowers MS, Akbarali HI, Hauser KF (2014) Interactive HIV-1 tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload. J Neurosci 34:12850\u201312864. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.5351-13.2014","journal-title":"J Neurosci"},{"key":"9867_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/aid.2008.0292","volume":"25","author":"LJ Garvey","year":"2009","unstructured":"Garvey LJ, Yerrakalva D, Winston A (2009) Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy AIDS. Res Hum Retroviruses 25:765\u2013769. \nhttps:\/\/doi.org\/10.1089\/aid.2008.0292","journal-title":"Res Hum Retroviruses"},{"issue":"50","key":"9867_CR39","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1523\/JNEUROSCI.2980-16.2016","volume":"36","author":"MV Green","year":"2016","unstructured":"Green MV, Thayer SA (2016) NMDARs adapt to neurotoxic HIV protein tat downstream of a GluN2A-ubiquitin ligase signaling pathway. J Neurosci 36(50):12640\u201312649. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.2980-16.2016","journal-title":"J Neurosci"},{"issue":"1","key":"9867_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11064-018-2502-2","volume":"44","author":"Matthew V. Green","year":"2018","unstructured":"Green MV, Raybuck JD, Zhang X, Wu MM, Thayer SA (2018) Scaling synapses in the presence of HIV. Neurochem Res. \nhttps:\/\/doi.org\/10.1007\/s11064-018-2502-2","journal-title":"Neurochemical Research"},{"key":"9867_CR41","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1530-0277.2010.01219.x","volume":"34","author":"NR Gubner","year":"2010","unstructured":"Gubner NR, Wilhelm CJ, Phillips TJ, Mitchell SH (2010) Strain differences in behavioral inhibition in a go\/no-go task demonstrated using 15 inbred mouse strains alcohol. Clin Exp res 34:1353\u20131362. \nhttps:\/\/doi.org\/10.1111\/j.1530-0277.2010.01219.x","journal-title":"Clin Exp res"},{"key":"9867_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/13550280701258407","volume":"13","author":"JD Gupta","year":"2007","unstructured":"Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007) Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol 13:195\u2013202. \nhttps:\/\/doi.org\/10.1080\/13550280701258407","journal-title":"J Neurovirol"},{"key":"9867_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1570162X13666150311163733","volume":"13","author":"YK Hahn","year":"2015","unstructured":"Hahn YK, Masvekar RR, Xu R, Hauser KF, Knapp PE (2015a) Chronic HIV-1 tat and HIV reduce Rbfox3\/NeuN: evidence for sex-related effects. Curr HIV res 13:10\u201320","journal-title":"Curr HIV res"},{"key":"9867_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00429-013-0676-6","volume":"220","author":"YK Hahn","year":"2015","unstructured":"Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE (2015b) Effects of chronic HIV-1 tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior brain. Struct Funct 220:605\u2013623. \nhttps:\/\/doi.org\/10.1007\/s00429-013-0676-6","journal-title":"Struct Funct"},{"key":"9867_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11065-009-9087-0","volume":"19","author":"DJ Hardy","year":"2009","unstructured":"Hardy DJ, Vance DE (2009) The neuropsychology of HIV\/AIDS in older adults. Neuropsychol Rev 19:263\u2013272. \nhttps:\/\/doi.org\/10.1007\/s11065-009-9087-0","journal-title":"Neuropsychol Rev"},{"key":"9867_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.conb.2008.08.007","volume":"18","author":"T Harkany","year":"2008","unstructured":"Harkany T, Mackie K, Doherty P (2008) Wiring and firing neuronal networks: endocannabinoids take center stage. Curr Opin Neurobiol 18:338\u2013345. \nhttps:\/\/doi.org\/10.1016\/j.conb.2008.08.007","journal-title":"Curr Opin Neurobiol"},{"key":"9867_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/QAI.0b013e3181b563e7","volume":"53","author":"KM Harrison","year":"2010","unstructured":"Harrison KM, Song R, Zhang X (2010) Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 53:124\u2013130. \nhttps:\/\/doi.org\/10.1097\/QAI.0b013e3181b563e7","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9867_CR48","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1046\/j.1471-4159.1999.0731363.x","volume":"73","author":"NJ Haughey","year":"1999","unstructured":"Haughey NJ, Holden CP, Nath A, Geiger JD (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 73:1363\u20131374","journal-title":"J Neurochem"},{"key":"9867_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/glia.20746","volume":"57","author":"KF Hauser","year":"2009","unstructured":"Hauser KF, Hahn YK, Adjan VV, Zou S, Buch SK, Nath A, Bruce-Keller AJ, Knapp PE (2009) HIV-1 Tat and Morphine Have Interactive Effects on Oligodendrocyte Survival and Morphology. Glia 57:194\u2013206. \nhttps:\/\/doi.org\/10.1002\/glia.20746","journal-title":"Glia"},{"key":"9867_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3\u201316. \nhttps:\/\/doi.org\/10.1007\/s13365-010-0006-1","journal-title":"J Neurovirol"},{"key":"9867_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuropharm.2018.08.013","volume":"141","author":"DJ Hermes","year":"2018","unstructured":"Hermes DJ, Xu C, Poklis JL, Niphakis MJ, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S (2018) Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology 141:55\u201365. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.013","journal-title":"Neuropharmacology"},{"key":"9867_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/NMD.0b013e31824cc225","volume":"200","author":"KA Hestad","year":"2012","unstructured":"Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK (2012) Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis 200:336\u2013342. \nhttps:\/\/doi.org\/10.1097\/NMD.0b013e31824cc225","journal-title":"J Nerv Ment Dis"},{"key":"9867_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1385\/ENDO:29:2:217","volume":"29","author":"GE Hoffman","year":"2006","unstructured":"Hoffman GE, Merchenthaler I, Zup SL (2006) Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 29:217\u2013231. \nhttps:\/\/doi.org\/10.1385\/ENDO:29:2:217","journal-title":"Endocrine"},{"key":"9867_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","volume":"532","author":"CC Huang","year":"2001","unstructured":"Huang CC, Lo SW, Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532:731\u2013748","journal-title":"J Physiol"},{"key":"9867_CR55","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/bph.12298","volume":"171","author":"BM Ignatowska-Jankowska","year":"2014","unstructured":"Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA, Tao Q, O\u2019 Neal ST, Walentiny DM, Wiley JL, AH CBFL (2014) In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. Br J Pharmacol 171:1392\u20131407. \nhttps:\/\/doi.org\/10.1111\/bph.12298","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9867_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/jpet.114.222315","volume":"353","author":"Bogna Ignatowska-Jankowska","year":"2015","unstructured":"Ignatowska-Jankowska B, Wilkerson, JL, Mustafa, M, Abdullah, R, Niphakis, M, Wiley, JL, Cravatt, BF, Lichtman, A. H. (2015) Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice. J Pharmacol Exp Ther 353:424\u2013432 doi:\nhttps:\/\/doi.org\/10.1124\/jpet.114.222315","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"9867_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0023677213501659","volume":"47","author":"TL Jensen","year":"2013","unstructured":"Jensen TL, Kiersgaard MK, Sorensen DB, Mikkelsen LF (2013) Fasting of mice: a review. Lab Anim 47(4):225\u2013240. \nhttps:\/\/doi.org\/10.1177\/0023677213501659","journal-title":"Lab Anim"},{"key":"9867_CR58","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1073\/pnas.1308673110","volume":"110","author":"TP Johnson","year":"2013","unstructured":"Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-tat protein proc. Natl Acad Sci U S a 110:13588\u201313593. \nhttps:\/\/doi.org\/10.1073\/pnas.1308673110","journal-title":"Natl Acad Sci U S a"},{"key":"9867_CR59","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10461-010-9744-6","volume":"15","author":"JA Joska","year":"2011","unstructured":"Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2011) Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa AIDS. Behav 15:1197\u20131203. \nhttps:\/\/doi.org\/10.1007\/s10461-010-9744-6","journal-title":"Behav"},{"key":"9867_CR60","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988\u2013994. \nhttps:\/\/doi.org\/10.1038\/35073667","journal-title":"Nature"},{"key":"9867_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/adb.12023","volume":"19","author":"JP Kesby","year":"2014","unstructured":"Kesby JP, Hubbard DT, Markou A, Semenova S (2014) Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice addiction. Biology 19:593\u2013605. \nhttps:\/\/doi.org\/10.1111\/adb.12023","journal-title":"Biology"},{"key":"9867_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.euroneuro.2014.07.014","volume":"25","author":"JP Kesby","year":"2015","unstructured":"Kesby JP, Markou A, Semenova S, Translational Methamphetamine ARCG (2015) Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice. Eur Neuropsychopharmacol 25:141\u2013150. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"9867_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2011.07.024","volume":"502","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kale RK, McLean P, Baquer NZ (2011) Protective effects of 17beta estradiol on altered age related neuronal parameters in female rat brain. Neurosci Lett 502:56\u201360. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2011.07.024","journal-title":"Neurosci Lett"},{"key":"9867_CR64","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.1128\/JVI.74.19.9214-9221.2000","volume":"74","author":"O Kutsch","year":"2000","unstructured":"Kutsch O, Oh J, Nath A, Benveniste EN (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74:9214\u20139221","journal-title":"J Virol"},{"issue":"11","key":"9867_CR65","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","volume":"14","author":"I. Lastres-Becker","year":"2001","unstructured":"Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernandez-Ruiz JJ (2001) Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets Eur J Neurosci 14:1827-1832","journal-title":"European Journal of Neuroscience"},{"issue":"8","key":"9867_CR66","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.neuint.2010.10.010","volume":"57","author":"Jasinda H. Lee","year":"2010","unstructured":"Lee JH, Agacinski G, Williams JH, Wilcock GK, Esiri MM, Francis PT, Wong PT, Chen CP, Lai MK (2010) Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex Neurochem Int 57:985-989. \nhttps:\/\/doi.org\/10.1016\/j.neuint.2010.10.010","journal-title":"Neurochemistry International"},{"key":"9867_CR67","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1124\/mol.110.069427","volume":"78","author":"AH Lichtman","year":"2010","unstructured":"Lichtman AH, Blankman JL, Cravatt BF (2010) Endocannabinoid overload. Mol Pharmacol 78:993\u2013995. \nhttps:\/\/doi.org\/10.1124\/mol.110.069427","journal-title":"Mol Pharmacol"},{"key":"9867_CR68","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410330218","volume":"33","author":"SA Lipton","year":"1993","unstructured":"Lipton SA (1993) Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33:227\u2013228. \nhttps:\/\/doi.org\/10.1002\/ana.410330218","journal-title":"Ann Neurol"},{"key":"9867_CR69","first-page":"17","volume":"1","author":"X Liu","year":"1996","unstructured":"Liu X, Marder K, Stern Y, Dooneief G, Bell K, Todak G, Joseph M, Elsadr W, Williams JB, Ehrhardt A, Stein Z, Mayeux R (1996) Gender differences in HIV-related neurological progression in a cohort of injecting drug users followed for 3.5 years. J NeuroAIDS 1:17\u201330","journal-title":"J NeuroAIDS"},{"key":"9867_CR70","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/82199","volume":"6","author":"Y Liu","year":"2000","unstructured":"Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat med 6:1380\u20131387. \nhttps:\/\/doi.org\/10.1038\/82199","journal-title":"Nat med"},{"key":"9867_CR71","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.109.156216","volume":"331","author":"Q Liu","year":"2009","unstructured":"Liu Q, Bhat M, Bowen WD, Cheng J (2009) Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. J Pharmacol Exp Ther 331:1062\u20131070. \nhttps:\/\/doi.org\/10.1124\/jpet.109.156216","journal-title":"J Pharmacol Exp Ther"},{"key":"9867_CR72","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1124\/jpet.105.099630","volume":"317","author":"F Longordo","year":"2006","unstructured":"Longordo F, Feligioni M, Chiaramonte G, Sbaffi PF, Raiteri M, Pittaluga A (2006) The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones. J Pharmacol Exp Ther 317:1097\u20131105. \nhttps:\/\/doi.org\/10.1124\/jpet.105.099630","journal-title":"J Pharmacol Exp Ther"},{"key":"9867_CR73","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbr.2010.05.027","volume":"214","author":"M Loos","year":"2010","unstructured":"Loos M, Staal J, Schoffelmeer ANM, Smit AB, Spijker S, Pattij T (2010) Inhibitory control and response latency differences between C57BL\/6J and DBA\/2J mice in a go\/no-go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Behavioural brain research 214:216\u2013224. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2010.05.027","journal-title":"Behavioural brain research"},{"key":"9867_CR74","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410370314","volume":"37","author":"DS Magnuson","year":"1995","unstructured":"Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37:373\u2013380. \nhttps:\/\/doi.org\/10.1002\/ana.410370314","journal-title":"Ann Neurol"},{"key":"9867_CR75","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.1523\/JNEUROSCI.0598-13.2013","volume":"33","author":"DF Marker","year":"2013","unstructured":"Marker DF, Tremblay ME, Puccini JM, Barbieri J, Gantz Marker MA, Loweth CJ, Muly EC, Lu SM, Goodfellow VS, Dewhurst S, Gelbard HA (2013) The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders. J Neurosci 33:9998\u201310010. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.0598-13.2013","journal-title":"J Neurosci"},{"key":"9867_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13365-016-0447-2","volume":"22","author":"WD Marks","year":"2016","unstructured":"Marks WD, Paris JJ, Schier CJ, Denton MD, Fitting S, McQuiston AR, Knapp PE, Hauser KF (2016) HIV-1 tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations. J Neurovirol 22:747\u2013762. \nhttps:\/\/doi.org\/10.1007\/s13365-016-0447-2","journal-title":"J Neurovirol"},{"key":"9867_CR77","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G Marsicano","year":"1999","unstructured":"Marsicano G, Lutz B (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:4213\u20134225","journal-title":"Eur J Neurosci"},{"key":"9867_CR78","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84\u201388. \nhttps:\/\/doi.org\/10.1126\/science.1088208","journal-title":"Science"},{"key":"9867_CR79","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.410420618","volume":"42","author":"E Masliah","year":"1997","unstructured":"Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. The HIV Neurobehavioral Research Center Ann Neurol 42:963\u2013972. \nhttps:\/\/doi.org\/10.1002\/ana.410420618","journal-title":"The HIV Neurobehavioral Research Center Ann Neurol"},{"issue":"S1","key":"9867_CR80","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.cdd.4401577","volume":"12","author":"M P Mattson","year":"2005","unstructured":"Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia cell death differ. 12 Suppl 1:893-904. \nhttps:\/\/doi.org\/10.1038\/sj.cdd.4401577","journal-title":"Cell Death & Differentiation"},{"key":"9867_CR81","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.4049\/jimmunol.1302915","volume":"193","author":"R Maung","year":"2014","unstructured":"Maung R, Hoefer MM, Sanchez AB, Sejbuk NE, Medders KE, Desai MK, Catalan IC, Dowling CC, de Rozieres CM, Garden GA, Russo R, Roberts AJ, Williams R, Kaul M (2014) CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120. J Immunol 193:1895\u20131910. \nhttps:\/\/doi.org\/10.4049\/jimmunol.1302915","journal-title":"J Immunol"},{"key":"9867_CR82","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fnbeh.2017.00212","volume":"11","author":"KA McLaurin","year":"2017","unstructured":"McLaurin KA, Booze RM, Mactutus CF, Fairchild AJ (2017) Sex matters: robust sex differences in signal detection in the HIV-1 transgenic rat front. Behav Neurosci 11:212. \nhttps:\/\/doi.org\/10.3389\/fnbeh.2017.00212","journal-title":"Behav Neurosci"},{"key":"9867_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/187152612798994939","volume":"12","author":"S Mediouni","year":"2012","unstructured":"Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H, Mokhtari M, Moreau H, Tamalet C, Brunet C, Paul P, Dignat-George F, Stein A, Brouqui P, Spector SA, Campbell GR, Loret EP (2012) Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets 12:81\u201386","journal-title":"Infect Disord Drug Targets"},{"key":"9867_CR84","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1570162X13666150121111548","volume":"13","author":"S Mediouni","year":"2015","unstructured":"Mediouni S, Jablonski J, Paris JJ, Clementz MA, Thenin-Houssier S, McLaughlin JP, Valente ST (2015) Didehydro-cortistatin a inhibits HIV-1 tat mediated neuroinflammation and prevents potentiation of cocaine reward in tat transgenic mice. Curr HIV res 13:64\u201379","journal-title":"Curr HIV res"},{"key":"9867_CR85","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","volume":"51","author":"K Monory","year":"2006","unstructured":"Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wolfel B, Dodt HU, Zieglgansberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51:455\u2013466. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2006.07.006","journal-title":"Neuron"},{"key":"9867_CR86","doi-asserted-by":"publisher","unstructured":"Mukherjee A, Caroni P (2018) Infralimbic cortex is required for learning alternatives to prelimbic promoted associations through reciprocal connectivity. Nature Communications 9 doi:\nhttps:\/\/doi.org\/10.1038\/s41467-018-05318-x","DOI":"10.1038\/s41467-018-05318-x"},{"issue":"8","key":"9867_CR87","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/cercor\/bhp274","volume":"20","author":"V Musante","year":"2010","unstructured":"Musante V, Summa M, Neri E, Puliti A, Godowicz TT, Severi P, Battalglia G, Raiteri M, Pittaluga A (2010) The HIV-1 viral protein tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings. Cereb Cortex 20(8):1974\u20131984. \nhttps:\/\/doi.org\/10.1093\/cercor\/bhp274","journal-title":"Cereb Cortex"},{"key":"9867_CR88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12031-010-9472-4","volume":"43","author":"V Naidoo","year":"2011","unstructured":"Naidoo V, Nikas SP, Karanian DA, Hwang J, Zhao J, Wood JT, Alapafuja SO, Vadivel SK, Butler D, Makriyannis A, Bahr BA (2011) A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. J Mol Neurosci 43:493\u2013502. \nhttps:\/\/doi.org\/10.1007\/s12031-010-9472-4","journal-title":"J Mol Neurosci"},{"issue":"Suppl 2","key":"9867_CR89","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1086\/344528","volume":"186","author":"A Nath","year":"2002","unstructured":"Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J infect dis 186(Suppl 2):S193\u2013S198. \nhttps:\/\/doi.org\/10.1086\/344528","journal-title":"J infect dis"},{"key":"9867_CR90","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1128\/JVI.70.3.1475-1480.1996","volume":"70","author":"A Nath","year":"1996","unstructured":"Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD (1996) Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J Virol 70:1475\u20131480","journal-title":"J Virol"},{"key":"9867_CR91","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/cn400116z","volume":"4","author":"MJ Niphakis","year":"2013","unstructured":"Niphakis MJ, Cognetta AB 3rd, Chang JW, Buczynski MW, Parsons LH, Byrne F, Burston JJ, Chapman V, Cravatt BF (2013) Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors ACS. Chem Neurosci 4:1322\u20131332. \nhttps:\/\/doi.org\/10.1021\/cn400116z","journal-title":"Chem Neurosci"},{"key":"9867_CR92","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/npp.2013.201","volume":"39","author":"JJ Paris","year":"2014","unstructured":"Paris JJ, Carey AN, Shay CF, Gomes SM, He JJ, McLaughlin JP (2014a) Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice. Neuropsychopharmacology 39:380\u2013388. \nhttps:\/\/doi.org\/10.1038\/npp.2013.201","journal-title":"Neuropsychopharmacology"},{"key":"9867_CR93","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.yhbeh.2014.04.001","volume":"65","author":"JJ Paris","year":"2014","unstructured":"Paris JJ, Fenwick J, McLaughlin JP (2014b) Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS. Hormones and behavior 65:445\u2013453. \nhttps:\/\/doi.org\/10.1016\/j.yhbeh.2014.04.001","journal-title":"Hormones and behavior"},{"key":"9867_CR94","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00213-013-3385-1","volume":"231","author":"JJ Paris","year":"2014","unstructured":"Paris JJ, Singh HD, Ganno ML, Jackson P, McLaughlin JP (2014c) Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl) 231:2349\u20132360. \nhttps:\/\/doi.org\/10.1007\/s00213-013-3385-1","journal-title":"Psychopharmacology (Berl)"},{"key":"9867_CR95","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbr.2015.05.021","volume":"291","author":"JJ Paris","year":"2015","unstructured":"Paris JJ, Singh HD, Carey AN, McLaughlin JP (2015) Exposure to HIV-1 tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice. Behav brain res 291:209\u2013218. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2015.05.021","journal-title":"Behav brain res"},{"key":"9867_CR96","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbi.2016.01.007","volume":"55","author":"Jason J. Paris","year":"2016","unstructured":"Paris JJ, Zou S, Hahn YK, Knapp PE, Hauser KF (2016) 5alpha-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 tat brain, behavior, and immunity. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2016.01.007","journal-title":"Brain, Behavior, and Immunity"},{"key":"9867_CR97","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00213-014-3696-x","volume":"232","author":"LA Parker","year":"2015","unstructured":"Parker LA, Niphakis MJ, Downey R, Limebeer CL, Rock EM, Sticht MA, Morris H, Abdullah RA, Lichtman AH, Cravatt BF (2015) Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus. Psychopharmacology (Berl) 232:583\u2013593. \nhttps:\/\/doi.org\/10.1007\/s00213-014-3696-x","journal-title":"Psychopharmacology (Berl)"},{"key":"9867_CR98","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/adb.12461","volume":"22","author":"M Pascual","year":"2017","unstructured":"Pascual M, Montesinos J, Marcos M, Torres JL, Costa-Alba P, Garcia-Garcia F, Laso FJ, Guerri C (2017) Gender differences in the inflammatory cytokine and chemokine profiles induced by binge ethanol drinking in adolescence. Addict Biol 22:1829\u20131841. \nhttps:\/\/doi.org\/10.1111\/adb.12461","journal-title":"Addict Biol"},{"key":"9867_CR99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S0029665113003649","volume":"73","author":"RG Pertwee","year":"2014","unstructured":"Pertwee RG (2014) Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications proc. Nutr Soc 73:96\u2013105. \nhttps:\/\/doi.org\/10.1017\/S0029665113003649","journal-title":"Nutr Soc"},{"key":"9867_CR100","first-page":"51","volume":"11","author":"S Petrosino","year":"2010","unstructured":"Petrosino S, Di Marzo V (2010) FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs 11:51\u201362","journal-title":"Curr Opin Investig Drugs"},{"key":"9867_CR101","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1523\/JNEUROSCI.0650-14.2015","volume":"35","author":"JM Puccini","year":"2015","unstructured":"Puccini JM, Marker DF, Fitzgerald T, Barbieri J, Kim CS, Miller-Rhodes P, Lu SM, Dewhurst S, Gelbard HA (2015) Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders. J Neurosci 35:5271\u20135283. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.0650-14.2015","journal-title":"J Neurosci"},{"key":"9867_CR102","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904\u20131913. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4540-04.2005","journal-title":"J Neurosci"},{"key":"9867_CR103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jsbmb.2011.06.008","volume":"127","author":"AK Rao","year":"2011","unstructured":"Rao AK, Dietrich AK, Ziegler YS, Nardulli AM (2011) 17beta-estradiol-mediated increase in cu\/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia the journal of steroid biochemistry and molecular. Biology 127:382\u2013389. \nhttps:\/\/doi.org\/10.1016\/j.jsbmb.2011.06.008","journal-title":"Biology"},{"key":"9867_CR104","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1523\/JNEUROSCI.0226-17.2017","volume":"37","author":"JD Raybuck","year":"2017","unstructured":"Raybuck JD, Hargus NJ, Thayer SA (2017) A GluN2B-selective NMDAR antagonist reverses synapse loss and cognitive impairment produced by the HIV-1 protein tat. J Neurosci 37:7837\u20137847. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.0226-17.2017","journal-title":"J Neurosci"},{"key":"9867_CR105","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","volume":"163","author":"TW Robbins","year":"2002","unstructured":"Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362\u2013380. \nhttps:\/\/doi.org\/10.1007\/s00213-002-1154-7","journal-title":"Psychopharmacology (Berl)"},{"key":"9867_CR106","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.bbi.2011.03.017","volume":"25","author":"S Rossi","year":"2011","unstructured":"Rossi S, Furlan R, De Chiara V, Muzio L, Musella A, Motta C, Studer V, Cavasinni F, Bernardi G, Martino G, Cravatt BF, Lutz B, Maccarrone M, Centonze D (2011) Cannabinoid CB1 receptors regulate neuronal TNF-alpha effects in experimental autoimmune encephalomyelitis brain. Behav Immun 25:1242\u20131248. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2011.03.017","journal-title":"Behav Immun"},{"key":"9867_CR107","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1097\/QAD.0b013e3282f08c2f","volume":"21","author":"AR Sas","year":"2007","unstructured":"Sas AR, Bimonte-Nelson HA, Tyor WR (2007) Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain. AIDS 21:2151\u20132159. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e3282f08c2f","journal-title":"AIDS"},{"key":"9867_CR108","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"9867_CR109","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.yhbeh.2012.02.018","volume":"62","author":"JM Schwarz","year":"2012","unstructured":"Schwarz JM, Bilbo SD (2012) Sex, glia, and development: interactions in health and disease. Horm Behav 62:243\u2013253. \nhttps:\/\/doi.org\/10.1016\/j.yhbeh.2012.02.018","journal-title":"Horm Behav"},{"key":"9867_CR110","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10461-010-9815-8","volume":"15","author":"JC Scott","year":"2011","unstructured":"Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I, Group HIVNRC (2011) Neurocognitive consequences of HIV infection in older adults: an evaluation of the \"cortical\" hypothesis. AIDS Behav 15:1187\u20131196. \nhttps:\/\/doi.org\/10.1007\/s10461-010-9815-8","journal-title":"AIDS Behav"},{"key":"9867_CR111","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1476-5381.2010.00735.x","volume":"160","author":"EL Scotter","year":"2010","unstructured":"Scotter EL, Abood ME, Glass M (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160:480\u2013498. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2010.00735.x","journal-title":"Br J Pharmacol"},{"key":"9867_CR112","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/mol.54.3.459","volume":"54","author":"M Shen","year":"1998","unstructured":"Shen M, Thayer SA (1998) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54:459\u2013462","journal-title":"Mol Pharmacol"},{"key":"9867_CR113","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1006\/exnr.2001.7649","volume":"169","author":"MA Silverdale","year":"2001","unstructured":"Silverdale MA, McGuire S, McInnes A, Crossman AR, Brotchie JM (2001) Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease. Exp Neurol 169:400\u2013406. \nhttps:\/\/doi.org\/10.1006\/exnr.2001.7649","journal-title":"Exp Neurol"},{"key":"9867_CR114","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","volume":"348","author":"MX Tang","year":"1996","unstructured":"Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429\u2013432. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(96)03356-9","journal-title":"Lancet"},{"key":"9867_CR115","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/367188a0","volume":"367","author":"SM Toggas","year":"1994","unstructured":"Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188\u2013193. \nhttps:\/\/doi.org\/10.1038\/367188a0","journal-title":"Nature"},{"key":"9867_CR116","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","volume":"83","author":"K Tsou","year":"1998","unstructured":"Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393\u2013411","journal-title":"Neuroscience"},{"key":"9867_CR117","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1007\/s00213-017-4668-8","volume":"234","author":"M Van den Buuse","year":"2017","unstructured":"Van den Buuse M, Low JK, Kwek P, Martin S, Gogos A (2017) Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice. Psychopharmacology (Berl) 234:2727\u20132735. \nhttps:\/\/doi.org\/10.1007\/s00213-017-4668-8","journal-title":"Psychopharmacology (Berl)"},{"key":"9867_CR118","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archgenpsychiatry.2008.530","volume":"66","author":"K Van Laere","year":"2009","unstructured":"Van Laere K, Goffin K, Bormans G, Casteels C, Mortelmans L, de Hoon J, Grachev I, Vandenbulcke M, Pieters G (2009) Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. Arch Gen Psychiatry 66:196\u2013204. \nhttps:\/\/doi.org\/10.1001\/archgenpsychiatry.2008.530","journal-title":"Arch Gen Psychiatry"},{"key":"9867_CR119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12993-017-0129-0","volume":"13","author":"YQ Wang","year":"2017","unstructured":"Wang YQ, Pan Y, Zhu S, Wang YG, Shen ZH, Wang K (2017) Selective impairments of alerting and executive control in HIV-infected patients: evidence from attention network test. Behav Brain Funct 13:11. \nhttps:\/\/doi.org\/10.1186\/s12993-017-0129-0","journal-title":"Behav Brain Funct"},{"key":"9867_CR120","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","volume":"63","author":"TM Westlake","year":"1994","unstructured":"Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63:637\u2013652","journal-title":"Neuroscience"},{"issue":"5","key":"9867_CR121","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13550280600964576","volume":"12","author":"Valerie Wojna","year":"2006","unstructured":"Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath a (2006) Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12:356\u2013364 doi:\nhttps:\/\/doi.org\/10.1080\/13550280600964576","journal-title":"Journal of Neurovirology"},{"issue":"2","key":"9867_CR122","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11481-016-9664-y","volume":"11","author":"Changqing Xu","year":"2016","unstructured":"Xu C, Hermes DJ, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S (2016) Cannabinoids occlude the HIV-1 tat-induced decrease in GABAergic neurotransmission in prefrontal cortex slices. J Neuroimmune Pharmacol. \nhttps:\/\/doi.org\/10.1007\/s11481-016-9664-y","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"9867_CR123","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mcn.2017.07.003","volume":"83","author":"C Xu","year":"2017","unstructured":"Xu C, Hermes DJ, Nwanguma B, Jacobs IR, Mackie K, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska B, Fitting S (2017) Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 tat protein. Mol cell Neurosci 83:92\u2013102. \nhttps:\/\/doi.org\/10.1016\/j.mcn.2017.07.003","journal-title":"Mol cell Neurosci"},{"key":"9867_CR124","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygcen.2016.03.005","volume":"239","author":"AK Yadawa","year":"2016","unstructured":"Yadawa AK, Chaturvedi CM (2016) Expression of stress hormones AVP and CRH in the hypothalamus of Mus musculus following water and food deprivation. Gen Comp Endocrinol 239:13\u201320. \nhttps:\/\/doi.org\/10.1016\/j.ygcen.2016.03.005","journal-title":"Gen Comp Endocrinol"},{"key":"9867_CR125","unstructured":"Yi\u011fit S, Mendes M (2018) Which effect size measure is appropriate for one-way and two-way ANOVA models? A Monte Carlo Simulation Study vol 16"},{"key":"9867_CR126","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.neuro.2008.01.006","volume":"29","author":"XM Zhang","year":"2008","unstructured":"Zhang XM, Zhu SW, Duan RS, Mohammed AH, Winblad B, Zhu J (2008) Gender differences in susceptibility to kainic acid-induced neurodegeneration in aged C57BL\/6 mice. Neurotoxicology 29:406\u2013412. \nhttps:\/\/doi.org\/10.1016\/j.neuro.2008.01.006","journal-title":"Neurotoxicology"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-019-09867-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:03:10Z","timestamp":1596153790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-019-09867-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09867-w","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}